These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32079308)
1. Role of Serum and Urine Biomarkers (PLA Maifata SM; Hod R; Zakaria F; Ghani FA Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32079308 [TBL] [Abstract][Full Text] [Related]
2. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of M Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127 [TBL] [Abstract][Full Text] [Related]
4. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans. Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188 [TBL] [Abstract][Full Text] [Related]
6. Primary Membranous Glomerulonephritis: The Role of Serum and Urine Biomarkers in Patient Management. Maifata SM; Hod R; Zakaria F; Abd Ghani F Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31683874 [TBL] [Abstract][Full Text] [Related]
7. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy. Tian C; Li L; Liu T; Qu X; Qiu Y Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982 [TBL] [Abstract][Full Text] [Related]
8. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain. L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294 [TBL] [Abstract][Full Text] [Related]
9. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study. Fouad MA; Mahedy AW; Mansour AE; Fouad NA Egypt J Immunol; 2020 Jun; 27(2):1-9. PubMed ID: 33548972 [TBL] [Abstract][Full Text] [Related]
10. Validation of phospholipase A Dai P; Campbell D; Culican S; Brown DA; Byth K; Hissaria P; Ninnes R; Nankivell B; Lin MW Pathology; 2020 Aug; 52(5):546-551. PubMed ID: 32564921 [TBL] [Abstract][Full Text] [Related]
11. [Membranous glomerulonephritis : An example of individualized medicine in nephrology]. Stahl RAK; Hoxha E Internist (Berl); 2019 May; 60(5):440-449. PubMed ID: 30859275 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years. Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452 [TBL] [Abstract][Full Text] [Related]
13. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy. Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers to detect membranous nephropathy in Chinese patients. Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909 [TBL] [Abstract][Full Text] [Related]
15. Effects of phospholipase A Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908 [TBL] [Abstract][Full Text] [Related]
16. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity. Larsen CP; Cossey LN; Beck LH Mod Pathol; 2016 Apr; 29(4):421-6. PubMed ID: 26847174 [TBL] [Abstract][Full Text] [Related]
18. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy]. Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy. Hoxha E; Harendza S; Pinnschmidt HO; Tomas NM; Helmchen U; Panzer U; Stahl RA Nephrol Dial Transplant; 2015 Nov; 30(11):1862-9. PubMed ID: 26142398 [TBL] [Abstract][Full Text] [Related]
20. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings. Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]